跳至主要内容
临床试验/jRCT1050250212
jRCT1050250212招募中不适用

Study on the Feasibility of Coronary Access after Evolut FX+ Implantation

未提供0 个研究点目标入组 250 人开始时间: 待定
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
No limit 至 No limit(—)

入选标准

  • i: The study will include 100 patients who underwent TAVI using Evolut FX+ after June 1, 2025, and for whom CT scans were performed.
  • ii: It will also include 150 patients who underwent TAVI using Evolut FX before May 31, 2025, and for whom CT scans were performed.
  • For patients who underwent TAVI with Evolut FX, the study will include 150 consecutive cases among patients treated at the research institution who underwent CT imaging before May 31.

排除标准

  • creatinine clearance less than 30 mL/min
  • prosthetic valve dysfunction
  • bicuspid or unicuspid valves
  • for whom the procedure was unsuccessful
  • contrast agent allergy
  • When a proxy is required for any reason
  • When a subject refuses to participate in or continue the study

研究者

发起方
未提供

相似试验